Connect with us

Hi, what are you looking for?

Health News

Asthma more prevalent among autumn babies

A new research says the season when the baby is born may determine whether he or she is prone to asthma. There is a 30 percent risk of asthma for a baby who is born in the virus season just before severe winter as compared to those born in other seasons according to a study the reports of which will be published in the American Journal, of Respiratory and Critical Care Medicine’s December issue.

A senior study author and director of the Vanderbilt University School of Medicine, Nashville, Tenn’s Center for Asthma Research and Environmental Health Dr. Tina Hartert says that there is a high rate of asthma among children born in the fall months in the Northern Hemisphere which shows that certain viruses prevalent in winter like RSV could be causing this. She added that if we work towards prevention of these viruses, asthma in children can also be effectively prevented.
One of the most common infections is caused by the RSV or Respiratory Syncytial Virus. According to Hartert, at least 70 percent of infants suffered from RSV infection in US before they complete a year. Only those with severe infection carry the risk of asthma. Statistics show that at least forty percent of infants who are hospitalized for treatment of respiratory virus develop asthma as they approach their teen years.

Infants who were monitored for this study were followed from their birth through their childhood on to their teen years as a part of the Tennessee Medicaid Program.

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...